))
Exploring Psychedelics in Mental Health
Manage episode 471301734 series 3652710
Content provided by Dr. Paul E. Wylie. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Paul E. Wylie or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
This conversation explores the emerging field of psychedelic research in mental health, focusing on the potential of psychedelic medications to treat mood disorders. Dr. Paul Wylie, a neuropsychiatrist, discusses the historical context of mental health treatments, the evolution of psychedelics in therapy, and the mechanisms by which they may promote neuroplasticity and improve mental health outcomes. Katie Walker, a therapist and participant in a clinical trial, shares her personal experiences and insights into the therapeutic process, emphasizing the importance of safety and integration in treatment. This conversation delves into the evolving landscape of psychedelic therapy, focusing on the therapeutic toolbox available to clients, the future of psychedelic treatments, safety measures in clinical trials, and the financial aspects of participation in these studies. The speakers emphasize the importance of collaboration between therapists and clinical researchers to optimize the therapeutic experience while ensuring participant safety and rights.
5 episodes
Share
